# BridgeBio Pharma, Inc.: Form 4, filed Jun 1, 2020

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 4
- Filed: 2020-06-01
- Accepted by EDGAR: Jun 1, 2020, 17:15 ET
- Period: 2020-05-28
- Accession: 0001140361-20-012852
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000114036120012852/xslF345X03/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000114036120012852/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000114036120012852/xslF345X03/form4.xml

Filed Jun 1, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-012852. Last ingested by Listed: Nov 3, 2026, 19:31 ET. No prices; not investment advice.